Halaman 4 - Adenokarsinoma Dokter Terbaik - TOP-106 dokter

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Kinas berspesialisasi dalam bedah kanker kompleks, termasuk prosedur pankreas dan saluran empedu, di Rumah Sakit Büyük Anadolu.

• Ahli dalam bedah onkologi dengan fokus pada kanker gastrointestinal
• Melakukan bedah bariatrik dan metabolik tingkat lanjut
• Terampil dalam operasi kanker payudara dan tiroid

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Mengkhususkan diri secara eksklusif dalam radioterapi, Dr. Michael Van Kampen memberikan pendekatan perawatan terarget di Klinik Nordwest.

• Berfokus pada teknik radioterapi presisi
• Bekerja dengan teknologi radioterapi mutakhir
• Menjadi bagian dari tim onkologi multidisiplin

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Memimpin seluruh Pusat Onkologi sebagai Kepala Dokter di Assuta Medical Center.

• Spesialisasi dalam onkologi medis dan pengobatan kanker
• Memiliki pengalaman luas dalam mengelola kasus kanker yang kompleks
• Mengawasi perawatan pasien dan protokol departemen onkologi terkemuka

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Zalmanova berspesialisasi dalam radioterapi dengan fokus pada adenokarsinoma di Assuta Medical Center.

• Ahli radioterapi dengan keahlian dalam perawatan radiasi tertarget
• Bekerja di Assuta Medical Center, yang dikenal dengan perawatan onkologi mutakhir
• Menyusun rencana perawatan pribadi untuk pasien adenokarsinoma

Dr. Karen Drumea adalah seorang Spesialis Radioterapi dan Onkologis di Rambam Medical Center, yang berfokus pada rencana perawatan yang tepat dan efektif.

• Spesialisasi dalam radioterapi untuk adenokarsinoma
• Bekerja di Rambam Medical Center, lembaga kesehatan terkemuka
• Berdedikasi pada perawatan pasien yang dipersonalisasi

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Derin telah menulis lebih dari 30 publikasi ilmiah mengenai pengobatan keganasan dan merupakan nama yang diakui di kalangan ahli onkologi Turki dan Eropa.

• Spesialis terkemuka dalam onkologi medis di Rumah Sakit Liv Ulus
• Ahli dalam kanker gastrointestinal, paru-paru, dan ginekologi seperti rahim dan ovarium
• Penulis lebih dari 30 makalah penelitian nasional dan internasional
• Anggota aktif European Society for Medical Oncology (ESMO)
• Associate Professor dengan latar belakang klinis dan akademis yang luas

Prof. Madya Murat Ayhan berspesialisasi dalam onkologi molekuler dan imunoterapi di Liv Hospital Vadistanbul, dengan fokus pada pengobatan adenokarsinoma stadium lanjut.

• Penelitian ekstensif dalam uji klinis Fase II dan III untuk kanker payudara dan paru-paru
• Menerbitkan berbagai studi tentang hasil pengobatan kanker dan dampak COVID-19
• Anggota European Society of Medical Oncology (ESMO) dan Turkish Society of Medical Oncology
• Menulis bagian tentang terapi target dalam buku teks onkologi medis

Dr. Tarkan berspesialisasi dalam bedah kanker lambung yang kompleks, menggabungkan presisi bedah dengan kemajuan terbaru dalam onkologi.

• Anggota Asosiasi Bedah Bariatrik Turki
• Berafiliasi dengan Federasi Internasional untuk Bedah Obesitas dan Gangguan Metabolik
• Lulus dari Fakultas Kedokteran Universitas Dicle

Dr. Lee Kwang Beom adalah seorang ahli onkoginekologi yang berspesialisasi dalam bedah laparoskopi di Gachon University Gil Medical Center.

• Spesialis dalam operasi laparoskopi untuk pengobatan kanker
• Berfokus secara khusus pada kasus onkologi ginekologi
• Menerapkan teknik bedah invasif minimal

Spesialis dalam teknik laser tingkat lanjut untuk prosedur urologi, termasuk perawatan prostat dan kandung kemih di Dievo Surgery Center.

• Melakukan enukleasi laser dan vaporisasi prostat
• Menjadi ahli dalam teknik pengangkatan batu ginjal minimal invasif
• Terampil dalam nefrektomi radikal laparoskopi dan bedah plastik pelvi-ureteral
• Melakukan rekonstruksi uretra yang kompleks dan perbaikan kandung kemih